- Managing Rheumatic/Immune Diseases During COVID-19 - PracticalPainManagement.com
- Visual Diagnosis: Sudden-Onset Decreased Vision in a Healthy Teenage Boy - AAP News
- High-Versus Low-Dose Aspirin in the Treatment of Kawasaki Disease - AAP News
- Use of C-Reactive Protein and Ferritin Biomarkers in Daily Pediatric Practice - AAP News
- Health-related quality of life in patients with immune mediated inflammatory diseases: A cross-sectional, multidisciplinary study - MD Linx
- Health-related quality of life in patients with immune mediated inflammatory diseases: A cross-sectional, multidisciplinary study - MD Linx
- InflaRx NV (IFRX) Doses First Patient in Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx's anti-C5a Technology - StreetInsider.com
- Vasculitis Drug Market: Industry Size, Growth, Revenue, Statistics and Forecast 2019-2025 - Jewish Life News
- Expert Consensus Guidelines for Remission Maintenance With Rituximab in ANCA-Associated Vasculitis - Rheumatology Advisor
- Vasculitis Treatment Market Growth, Trends, Size, Share, Demand And Top Growing Companies 2026 - Weekly Wall
- DARPin molecule reducing wet AMD treatment burden for patients - Ophthalmology Times
- DARPin molecule reducing wet AMD treatment burden for patients - Modern Retina
- 'Selfless’ mum, 48, dies of Covid-19 after doctors discover unknown health issue - Mirror Online
- Drug-Induced Photosensitivity - Monthly Prescribing Reference
- Older Age, Infections Tied to Poor Outcomes in AAV with Lung... - ANCA Vasculitis News
Connect with us on social media!
Participate in Research
The Vasculitis Foundation's updated website design was generously funded with a grant by Genentech.
